Methyl 4,5-di(1H-imidazol-1-yl)-2-nitrobenzoate, 95.0%, 250mg

1-(4-FLUOROPHENYL)CYCLOHEXANECARBOXYLIC ACID, 95.0%, 1g

2-Chloropyridine-4-carbonyl chloride, 95.0%, 5g

Bismuthiol II>98.0%(HPLC)(T)25g

(2E)-1-(2,4-dimethoxyphenyl)-3-[4-(propan-2-yl)phenyl]prop-2-en-1-one, 95.0%, 2g

4-[(2,4-dioxo-1,3-thiazolidin-3-yl)methyl]benzoic acid, 95.0%, 1g

(S)-2-(Pyrrolidin-3-yloxy)pyridine hydrochloride, 95%, 1g

(3-Chloro-5-(pyrrolidin-1-yl)phenyl)boronic acid, 96%, 25g

Zinc dust, min. 98%, <63 µm, stabilized, 2.5 kg, glass packaging

1-Benzylpiperidine-3-carboxylic acid, 95.0%, 25g

Methyl 5-hydroxy-2-(trifluoromethyl)benzoate, 250mg

7-FLUORO-2-SULFANYLIDENE-1,2,3,4-TETRAHYDROQUINAZOLIN-4-ONE, 95%, 100mg

5-Chloro-1-methyl-1H-pyrazol-4-amine, 97%, 250mg